SEC Form 4 · accession 0001144204-15-058680
Aevi Genomic Medicine, Inc. · GNMX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Garry Arthur Neil
Officer — Chief Scientific Officer
Period of report
Oct 6, 2015
Accepted (ET)
Oct 8, 2015 · 4:46 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001138776
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 6, 2015 | P | 15,384 | $6.50 | A | 39,774 | D |
Table II — derivative securities
No Table II lines on this filing.